Thus, the reduction in GM-CSF expression by SCD could lead to anti-inflammatory potential of inhibiting the NF-κB signaling pathway and reducing production of inflammatory biomarkers. The gene discussed is NFKB1; the disease is Schnyder corneal dystrophy.